Citi analyst Filippo Falorni lowered the firm’s price target on Clorox to $135 from $170 and keeps a Neutral rating on the shares. Post the recent staples underperformance, the analyst views sector valuations as more attractive. Into the Q3 reports, the firm continues to favor names with more emerging market exposure and lower private label penetration. Citi still expects near-term gross margin upside in Q3 but believes the market will not reward earnings beats on margins without solid sales trends.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CLX:
- Palo Alto Networks Stock (NASDAQ:PANW): Bank on Cybersecurity Concerns
- MGM Resorts (NYSE:MGM) Feels the Pinch from Cyberattack
- Clorox Stock (NYSE:CLX) Should Get Back on Track after Cyberattack
- O’Reilly upgraded, Yeti downgraded: Wall Street’s top analyst calls
- Clorox price target lowered to $120 from $160 at Evercore ISI